During this fireside chat, we welcome Lantern Pharma, ticker symbol of LTRN on the NASDAQ, and their CEO, Panna Sharma. Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody-drug conjugate (ADC) program.

This Fireside Chat was recorded during the Lytham Partners Spring 2023 Investor Conference.